According to the latest report by IMARC Group, titled “Fetal Bovine Serum Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global fetal bovine serum market reached a value of US$ XX Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.Fetal bovine serum (FBS) is an important component of animal cell culture media that is obtained from bovine fetuses of cows. It has numerous nutritional and macromolecular factors that are crucial for cell growth. Moreover, FBS also contains sugars, lipids, amino acids, hormones, low gamma globulin content, etc. This helps in supplying essential nutrients and facilitating cell survival and proliferation in eukaryotic cell culture. FBS also finds extensive applications in research, biotech drugs, manufacturing, and controlling human and veterinary vaccines.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report: https://www.imarcgroup.com/fetal-bovine-serum-market/requestsample
Fetal Bovine Serum Market Trends:
The escalating utilization of FBS in generating stem cells to treat acute and chronic lung damage due to the coronavirus infection (COVID-19), represents one of the key factors driving the global market. Additionally, numerous antibodies are being increasingly used in laboratories to keep cells alive for dividing, growing, evolving, etc., making FBS popular in various scientific research activities. Moreover, extensive R&D activities, along with rising investments by governing and private agencies for introducing novel biopharmaceuticals, are further catalyzing the market growth. Apart from this, the elevating demand for biopharma products due to the rising prevalence of acute and chronic diseases is also acting as a growth-inducing factor.
Key Market Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Atlas Biologicals Inc.
- Biological Industries (Sartorius AG)
- Bio-Techne Corporation
- Bovogen Biologicals Pty Ltd.
- General Electric Company
- HiMedia Laboratories
- Merck KGaA
- Rocky Mountain Biologicals
- TCS Biosciences Ltd
- Thermo Fisher Scientific Inc.
Breakup by Product:
- Charcoal Stripped
- Dialyzed Fetal Bovine Serum
- Exosome Depleted
- Stem Cell
Breakup by Application:
- Cell Culture
- Human and Animal Vaccine Production
Breakup by End User:
- Biotechnology and Pharmaceutical Companies
- Academic Institutes
- Research Laboratories
Breakup by Region:
- Middle East and Africa
- North America
- Latin America
Key highlights of the Report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800